• $78,792.00
    Market Cap
  • -95.65%
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
12/31/2020
Income Statement
Total Operating Revenue
166,111
N/A
Cost of Revenue
68,768
N/A
Gross Profit
97,343
N/A
Sales and Marketing Expense
19,762
N/A
Research and Development Expense
-14,796
N/A
Depreciation and Amortization Expense
123,646
N/A
Total Operating Expenses
1.3M
N/A
Operating Profit
-1.2M
N/A
Interest Income
N/A
N/A
Interest Expense
-489,123
N/A
Interest Income and Expense and Net
-489,123
N/A
Total Nonoperating Income and Expense
-3.7M
N/A
Income before Taxes
-5.0M
N/A
Income Taxes
30,185
N/A
Extraordinary Items
N/A
N/A
Net Income
-5.0M
N/A
Net Income from Continuing Operations Applicable to Common
-5.0M
N/A
Basic EPS and Net Income
0.00
N/A
Diluted EPS and Net Income
0.00
N/A
Basic Weighted Average Shares
2.8B
N/A
Diluted Weighted Average Shares
2.8B
N/A
Balance Sheet
Cash and Cash Equivalents
3,349
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3,349
N/A
Total Current Assets
23,449
N/A
Accumulated Depreciation
40,854
N/A
Property and Plant and Equipment and Net
60,203
N/A
Total Long-Term Assets
60,203
N/A
Total Assets
1.7M
N/A
Income Taxes Payable
N/A
N/A
Total Short-Term Debt
3.4M
N/A
Total Current Liabilities
10.4M
N/A
Total Long-Term Debt
1.2M
N/A
Total Long-Term Liabilities
416,788
N/A
Total Liabilities
12.0M
N/A
Retained Earnings
-19.3M
N/A
Total Stockholders Equity
-10.4M
N/A
Total Shares Outstanding
3.6B
N/A
Cash Flow
Cash from Operating Activities
-523,534
N/A
Capital Expenditures
7,272
N/A
Cash from Investing Activities
-7,272
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
529,696
N/A
Financials Ratio
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Return on Assets
N/A
N/A
Return on Equity
N/A
N/A
Revenue Growth
N/A
N/A
Current Ratio
N/A
N/A
Cash Ratio
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow